General Information of the Compound
Compound ID
CP0092725
Compound Name
N-(4-chlorophenyl)-2-[2-(1,2-oxazol-4-yl)ethyl]pyrazole-3-carboxamide
    Show/Hide
Structure
Formula
C15H13ClN4O2
Molecular Weight
316.748
Canonical SMILES
Clc1ccc(NC(=O)c2ccnn2CCc2cnoc2)cc1
    Show/Hide
InChI
InChI=1S/C15H13ClN4O2/c16-12-1-3-13(4-2-12)19-15(21)14-5-7-17-20(14)8-6-11-9-18-22-10-11/h1-5,7,9-10H,6,8H2,(H,19,21)
    Show/Hide
InChIKey
VNEZUFFYPVNFQZ-UHFFFAOYSA-N
Physicochemical Property
logP
3.0195
Rotatable Bonds
5
Heavy Atom Count
22
Polar Areas
72.95
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44431894
ChEMBL ID
CHEMBL232802
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS